Cost-effectiveness analyses and robust clinical outcome data are needed to justify broader inclusion across policies and to guide rational pricing.

New ‘no-limit’ health plans offer unmatched coverage—but questions remain on sustainability, claims support, and long-term ...

The Insurance Regulatory and Development Authority of India has established a committee. This is to assess license ...

The insurance regulator’s programme has the worthy aim of coverage for all by 2047, but we should adjust its strategic ...

Medi Assist’s Raksha Prime enables 2L+ cashless hospital discharges, reducing wait times by hours. AI-powered service aligns ...

The Bengaluru-based advisory firm also flagged concerns like conflict of interest regarding Venugopal on the ESOPs issue, as ...

HDFC Life, ICICI Prudential Life to report on July 15. The companies are likely to begin reconfiguring their product mix and ...

IRDAI’s 2024 master circular undoubtedly enhances consumer rights—faster claim processing, shorter waiting periods, and ...

In the absence of a full-time IRDAI chairman, the meeting will be held under the interim chairmanship of PK Arora, the senior ...